In Response to “Intratumor Distribution of Ki-67 Antigen Beyond Labeling Index for Clinical Decision Making: A New Way of Counting”

by Robert A. Belderbos, MD, Joachim G.J. V. Aerts, MD, PhD, Jan H. von der Thüsen, MD, PhD
Published 2021-09-01

Ki67 (MIB-1) as a Prognostic Marker for Clinical Decision Making Before Extended Pleurectomy Decortication in Malignant Pleural Mesothelioma

by Robert A. Belderbos, MD, Alexander P.W.M. Maat, MD, Sara J. Baart, PhD, Eva V.E Madsen, MD, PhD, Ad J.J.C. Bogers, MD, PhD, Robin Cornelissen, MD, PhD, Joachim G.J.V. Aerts, MD, PhD, Edris A.F. Mahtab, MD, PhD, Jan H. von der Thüsen, MD, PhD
Published 2021-04-01